FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136343499> ?p ?o ?g. }

• W3136343499 abstract "Total glucosides of paeony (TGP), an active compound extracted from the roots of Paeonia lactiflora Pallas, has been increasingly used as the adjunctive therapy for rheumatoid arthritis (RA) patients. Though TGP could mitigate the unanticipated adverse effects during the conventional treatment of RA, high-quality evidence-based meta-analysis data on this subject are still insufficient. The objective of this study is to evaluate the clinical safety of TGP adjuvant therapy in the RA treatment.PubMed, EMBASE, Web of Science, China Network Knowledge Infrastructure (CNKI), SinoMed and WanFang Data were retrieved for randomized controlled trials (RCTs) and cohort study about TGP adjuvant therapy in patients with RA up to 28 January 2021. Literatures with eligibility criteria and information were screened and extracted by two researchers independently. The RevMan5.3 software was used for data analysis with effect estimates as risk ratio (RR) with 95% confidence interval (CI).A total of 39 studies involving 3680 RA participants were included. There were 8 comparisons: TGP plus methotrexate (MTX) therapy versus MTX therapy, TGP plus leflunomide (LEF) therapy versus LEF therapy, TGP plus MTX and LEF therapy versus MTX plus LEF therapy, TGP plus tripterygium glycosides (TG) therapy versus TG therapy, TGP plus meloxicam (MLX) therapy versus MLX therapy and TGP plus sulfasalazine (SSZ) therapy versus SSZ therapy, TGP plus iguratimod (IGU) therapy versus IGU therapy, TGP plus prednisone acetate tablets (PAT) therapy versus PAT therapy. The meta-analysis results showed that the occurrence of hepatic adverse effect (RR = 0.31, 95% CI = 0.23-0.41, P < 0.00001) and leukopenia (RR = 0.41, 95% CI = 0.26-0.66, P = 0.0002) in TGP adjuvant therapy was significant decreased compared with non-TGP therapy. However, only TGP plus LEF therapy (RR = 0.22, 95% CI = 0.08-0.60, P = 0.003) and TGP plus MTX and LEF therapy (RR = 0.31, 95% CI = 0.22-0.42, P < 0.00001) had statistical difference in the subgroups of hepatic adverse effect. In leukopenia, TGP plus MTX and LEF therapy (RR = 0.47, 95% CI = 0.25-0.87, P = 0.02) had statistical difference.This meta-analysis indicated that TGP adjuvant therapy might alleviate the incidence of hepatic adverse effect and leukopenia for the RA treatment compared to non-TGP therapy. The clinical safety of TGP adjuvant therapy warrant further investigation in experimental studies." @default.
• W3136343499 created "2021-03-29" @default.
• W3136343499 creator A5001858374 @default.
• W3136343499 creator A5005215310 @default.
• W3136343499 creator A5016504908 @default.
• W3136343499 creator A5022488322 @default.
• W3136343499 creator A5028416174 @default.
• W3136343499 creator A5043818935 @default.
• W3136343499 creator A5048826252 @default.
• W3136343499 creator A5051858597 @default.
• W3136343499 creator A5080581580 @default.
• W3136343499 date "2021-03-26" @default.
• W3136343499 modified "2023-10-06" @default.
• W3136343499 title "Clinical safety of total glucosides of paeony adjuvant therapy for rheumatoid arthritis treatment: a systematic review and meta-analysis" @default.
• W3136343499 cites W1878991695 @default.
• W3136343499 cites W1981815467 @default.
• W3136343499 cites W1987565381 @default.
• W3136343499 cites W1997282832 @default.
• W3136343499 cites W2000972571 @default.
• W3136343499 cites W2037978153 @default.
• W3136343499 cites W2049516117 @default.
• W3136343499 cites W2064989711 @default.
• W3136343499 cites W2085125768 @default.
• W3136343499 cites W2088728349 @default.
• W3136343499 cites W2191871043 @default.
• W3136343499 cites W2460272198 @default.
• W3136343499 cites W2771736968 @default.
• W3136343499 cites W2785035668 @default.
• W3136343499 cites W2803973097 @default.
• W3136343499 cites W2891474673 @default.
• W3136343499 cites W2893429695 @default.
• W3136343499 cites W2912678610 @default.
• W3136343499 cites W2949790590 @default.
• W3136343499 cites W3023654020 @default.
• W3136343499 cites W3184123916 @default.
• W3136343499 cites W4211111012 @default.
• W3136343499 doi "https://doi.org/10.1186/s12906-021-03252-y" @default.
• W3136343499 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8004450" @default.
• W3136343499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33771151" @default.
• W3136343499 hasPublicationYear "2021" @default.
• W3136343499 type Work @default.
• W3136343499 sameAs 3136343499 @default.
• W3136343499 citedByCount "7" @default.
• W3136343499 countsByYear W31363434992022 @default.
• W3136343499 countsByYear W31363434992023 @default.
• W3136343499 crossrefType "journal-article" @default.
• W3136343499 hasAuthorship W3136343499A5001858374 @default.
• W3136343499 hasAuthorship W3136343499A5005215310 @default.
• W3136343499 hasAuthorship W3136343499A5016504908 @default.
• W3136343499 hasAuthorship W3136343499A5022488322 @default.
• W3136343499 hasAuthorship W3136343499A5028416174 @default.
• W3136343499 hasAuthorship W3136343499A5043818935 @default.
• W3136343499 hasAuthorship W3136343499A5048826252 @default.
• W3136343499 hasAuthorship W3136343499A5051858597 @default.
• W3136343499 hasAuthorship W3136343499A5080581580 @default.
• W3136343499 hasBestOaLocation W31363434991 @default.
• W3136343499 hasConcept C126322002 @default.
• W3136343499 hasConcept C168563851 @default.
• W3136343499 hasConcept C178790620 @default.
• W3136343499 hasConcept C185592680 @default.
• W3136343499 hasConcept C194671627 @default.
• W3136343499 hasConcept C197934379 @default.
• W3136343499 hasConcept C2775905006 @default.
• W3136343499 hasConcept C2776694085 @default.
• W3136343499 hasConcept C2776999253 @default.
• W3136343499 hasConcept C2777575956 @default.
• W3136343499 hasConcept C2777982462 @default.
• W3136343499 hasConcept C2781059491 @default.
• W3136343499 hasConcept C2781079059 @default.
• W3136343499 hasConcept C71924100 @default.
• W3136343499 hasConcept C95190672 @default.
• W3136343499 hasConceptScore W3136343499C126322002 @default.
• W3136343499 hasConceptScore W3136343499C168563851 @default.
• W3136343499 hasConceptScore W3136343499C178790620 @default.
• W3136343499 hasConceptScore W3136343499C185592680 @default.
• W3136343499 hasConceptScore W3136343499C194671627 @default.
• W3136343499 hasConceptScore W3136343499C197934379 @default.
• W3136343499 hasConceptScore W3136343499C2775905006 @default.
• W3136343499 hasConceptScore W3136343499C2776694085 @default.
• W3136343499 hasConceptScore W3136343499C2776999253 @default.
• W3136343499 hasConceptScore W3136343499C2777575956 @default.
• W3136343499 hasConceptScore W3136343499C2777982462 @default.
• W3136343499 hasConceptScore W3136343499C2781059491 @default.
• W3136343499 hasConceptScore W3136343499C2781079059 @default.
• W3136343499 hasConceptScore W3136343499C71924100 @default.
• W3136343499 hasConceptScore W3136343499C95190672 @default.
• W3136343499 hasIssue "1" @default.
• W3136343499 hasLocation W31363434991 @default.
• W3136343499 hasLocation W31363434992 @default.
• W3136343499 hasLocation W31363434993 @default.
• W3136343499 hasOpenAccess W3136343499 @default.
• W3136343499 hasPrimaryLocation W31363434991 @default.
• W3136343499 hasRelatedWork W2345056770 @default.
• W3136343499 hasRelatedWork W2368687706 @default.
• W3136343499 hasRelatedWork W2372955595 @default.
• W3136343499 hasRelatedWork W2378111268 @default.
• W3136343499 hasRelatedWork W2385166155 @default.
• W3136343499 hasRelatedWork W2394123269 @default.
• W3136343499 hasRelatedWork W2399951980 @default.
• W3136343499 hasRelatedWork W2755211090 @default.

• next